SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000893220-07-002390
Filing Date
2007-07-10
Accepted
2007-07-10 07:03:58
Documents
5
Period of Report
2006-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A PAR PHARMACEUTICAL COMPANIES, INC. w36851e10vqza.htm 10-Q/A 714379
2 CERTIFICATION BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER w36851exv31w1.htm EX-31.1 8227
3 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER w36851exv31w2.htm EX-31.2 8246
4 CERTIFICATION BY THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, PURSUANT TO SECTION w36851exv32w1.htm EX-32.1 3239
5 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER, PURSUANT TO SECTION 906 w36851exv32w2.htm EX-32.2 3237
  Complete submission text file 0000893220-07-002390.txt   738842
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-10827 | Film No.: 07970755
SIC: 2834 Pharmaceutical Preparations